Ed is currently a director of Binary Fountain, Carevive, Persivia, Phreesia, Tandem Diabetes (NASDAQ) and Vet’s First Choice and is a board observer at RedBrick. Ed previously served as a director of Animas Corporation (acquired by J&J), Centene Corporation (NYSE), Masimo Corporation (NASDAQ), Spinal Concepts (acquired by Abbott) and TYRX (acquired by Medtronic). He is a Trustee of Johns Hopkins Medicine, Johns Hopkins Health System and Mercy Health Services.
Previously, Ed was a founding partner of Cahill, Warnock & Company (now Camden Partners), a Baltimore venture capital firm, and a Managing Director of Alex. Brown & Sons, where he headed the firm’s Health Care group from 1986 to 1995. During his leadership at Alex. Brown & Sons, the firm underwrote public offerings or provided merger advisory services for over 200 health care companies, including the first publicly-held outpatient surgery, rehabilitation, and managed care companies, and several leading biopharmaceutical companies.
Ed received an AB from Williams College and a Master of Public and Private Management degree from Yale University.
Ed Cahill can be reached at firstname.lastname@example.org.